Brief: Arno Therapeutics reports Q1 adj loss of $0.05 per share
16/05/2016 21:30
May 16 (Reuters) - Arno Therapeutics Inc ARNI.PK
* Q1 adjusted non-gaap loss per share $0.05
Source text for Eikon: ID:nGNXMRLWSa
Further company coverage: ARNI.PK
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on Arno Therapeutics
See all newsBrief: Arno Therapeutics Announces Plans To Dissolve
Brief: Arno Therapeutics announces update to prostate cancer program
Brief: Arno Therapeutics reports Q1 adj loss of $0.05 per share
Brief: Arno Therapeutics reports Q3 loss per share $0.03
Brief: Arno Therapeutics Q1 adjusted non-GAAP loss per share $0.14